These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27 related articles for article (PubMed ID: 11370412)
1. [Nephrotoxicity after the use of intravenous X-ray contrast media in a type 2 diabetic being treated with metformin]. Bjarnason NH; Elung-Jensen T Ugeskr Laeger; 2006 May; 168(18):1772-3. PubMed ID: 16729932 [TBL] [Abstract][Full Text] [Related]
5. [Metformin should not be used by patients with reduced renal function]. Gudmundsdottir H; Brørs O; Os I Tidsskr Nor Laegeforen; 2008 Apr; 128(8):936-7. PubMed ID: 18431417 [No Abstract] [Full Text] [Related]
8. [Metformin. Mode of action and effect of monotherapy and combination therapy on glucose metabolism in type 2 diabetes]. Christiansen AL; Madsbad S Ugeskr Laeger; 2002 Apr; 164(15):2025-8. PubMed ID: 11985000 [TBL] [Abstract][Full Text] [Related]
9. Drugs and intravenous contrast media. Thompson NW; Thompson TJ; Love MH; Young MR BJU Int; 2000 Feb; 85(3):219-21. PubMed ID: 10671870 [No Abstract] [Full Text] [Related]
10. Oral hypoglycaemics. When not to use what. Phillips P; Braddon J Aust Fam Physician; 2002 Jul; 31(7):637-43. PubMed ID: 12143325 [TBL] [Abstract][Full Text] [Related]
11. Contrast-induced nephropathy after intravenous administration: fact or fiction? Katzberg RW; Lamba R Radiol Clin North Am; 2009 Sep; 47(5):789-800, v. PubMed ID: 19744594 [TBL] [Abstract][Full Text] [Related]
12. The safety of metformin in heart failure. Roberts F; Ryan GJ Ann Pharmacother; 2007 Apr; 41(4):642-6. PubMed ID: 17374622 [TBL] [Abstract][Full Text] [Related]